Urinary tract infections (UTIs) are the most common outpatient infections, with a lifetime incidence of 50-60% in adult women. This is a narrative review aimed at acting as an introduction to the epidemiology and burden of UTIs. This review is based on relevant literature according to the experience and expertise of the authors. The prevalence…
Therapeutic Advances in Urology Template
Write in a clean editor, then format for Therapeutic Advances in Urology in one click — DocuGuru applies the official SAGE template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Therapeutic Advances in Urology format
Therapeutic Advances in Urology is a peer-reviewed journal published by SAGE, covering Urinary Bladder and Prostate Research, Prostate Cancer Diagnosis and Treatment, Bladder and Urothelial Cancer Treatments.
| Publisher | SAGE |
|---|---|
| Reference style | Author–year (Harvard) Author–year — (Smith, 2023) in the text Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Therapeutic Advances in Urology, 12(3), pp. 45–58.
Formats any DOI in Therapeutic Advances in Urology style. No sign-up. |
| Publishes research in | Urinary Bladder and Prostate Research Prostate Cancer Diagnosis and Treatment Bladder and Urothelial Cancer Treatments Pelvic floor disorders treatments Urinary Tract Infections Management |
| ISSN | 1756-2872 |
| Citation impact (2-yr) | 2.88 |
| h-index | 56 |
| i10-index | 374 |
| Total citations | 15,116 |
| Article processing charge | $2,300 |
| Open access | Yes |
| Top institutions publishing here | University Hospital Southampton NHS Foundation Trust |
| Journal website | us.sagepub.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Therapeutic Advances in Urology per year
Citation impact of Therapeutic Advances in Urology by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Therapeutic Advances in Urology
Understanding individual and population-specific risk factors associated with recurrent urinary tract infections (UTIs) can help physicians tailor prophylactic strategies. Frequent intercourse, vulvovaginal atrophy, change of the local bacterial flora, history of UTIs during premenopause or in childhood, family history, and a nonsecretor blood type are substantiated risk factors for recurrent uncomplicated UTIs. This is a…
Iatrogenic injury to the ureter is a potentially devastating complication of modern surgery. The ureters are most often injured in gynecologic, colorectal, and vascular pelvic surgery. There is also potential for considerable ureteral injury during endoscopic procedures for ureteric pathology such as tumor or lithiasis. While maneuvers such as perioperative stenting have been touted as…
Cystitis, or inflammation of the bladder, has a direct effect on bladder function. Interstitial cystitis is a syndrome characterized by urinary bladder pain and irritative symptoms of more than 6 months duration. It commonly occurs in young to middle-aged women with no known cause and in fact represents a diagnosis of exclusion. Many factors have…
A major focus in urologic research is the identification of new biomarkers with improved specificity for clinically-significant prostate cancer. A promising new test based on prostate-specific antigen (PSA) is called the Prostate Health Index (PHI), which has recently been approved in the United States, Europe and Australia. PHI is a mathematical formula that combines total…